戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 score of a minimally important difference of more than or equal to 0.3.
2 ther detection of occult leukemia defined as more than or equal to 0.5% blasts with aberrant surface
3 p had presumed protective IgG concentrations more than or equal to 0.50 microg/mL to all 7 serotypes
4 eceiver-operating characteristic curves near more than or equal to 0.96 (p approximately 0.0001), sug
5 s had methylation of 0 genes and 48 (25%) of more than or equal to 1 gene.
6 ) received cardiopulmonary resuscitation for more than or equal to 1 minute and/or defibrillation.
7                                        GI in more than or equal to 1 year grafts is mostly antibody-m
8  first relapses (ATRA naive or off oral ATRA more than or equal to 1 year), or group 2 relapses (seco
9 es from 240 patients with grafts functioning more than or equal to 1 year.
10     The IR of allospecific CD154CD19 B cells more than or equal to 1.351 was associated with rejector
11 t 12 hours, expression of 64 probes differed more than or equal to 1.5-fold; none represented genes r
12 eristic analysis revealed that MDC:PDC ratio more than or equal to 1.52 was associated with rejector
13 onal subjects revealed that an MDC:PDC ratio more than or equal to 1.78 was associated with rejector
14 rrent 2 mg/kg per day methylprednisolone for more than or equal to 10 days.
15 ngs indicate that C4d positivity, defined as more than or equal to 10% by immunoperoxidase, is a stro
16 ogic risk, mean fluorescence intensity (MFI) more than or equal to 100 for class I and more than or e
17 l was detected in patients with class II MFI more than or equal to 1000 (75% vs. 91.9%, P=0.055).
18  resolution of anemia, defined as hemoglobin more than or equal to 11 g/dL.
19 on of age 45 years or more and cold ischemia more than or equal to 12 hr reached statistical signific
20 nors aged 45 years or more and cold ischemia more than or equal to 12 hr showed an adjusted absolute
21 han 200 mg/dL, or two fasting glucose levels more than or equal to 126 mg/dL beyond 30 days posttrans
22 ology and Chronic Health Evaluation II score more than or equal to 13, expected to require total pare
23 arance was defined by a creatinine clearance more than or equal to 130 mL/min/1.73 m.
24 ults 1) receiving mechanical ventilation for more than or equal to 14 days, 2) admitted to a ventilat
25 rds model: mean right atrial pressure (mRAP) more than or equal to 14 mm Hg and 6-min walk test dista
26 ginal waitlist exponent plus 0.7; if mRAP is more than or equal to 14 mm Hg, minus 0.35; for every 10
27 e was 3 months, and duration of response was more than or equal to 14 months.
28 dications (n=8) or average blood pressure of more than or equal to 140 systolic or 90 mm Hg diastolic
29 a Simplified Acute Physiology Score II score more than or equal to 15 and at least one specific proce
30 l for patients with a pre-TIPS MELD score of more than or equal to 15 was 3 months (1-59 months) comp
31 ft loss for patients with a pre-TIPS MELD of more than or equal to 15 were significantly higher than
32 hology, karyotype, and prognosis in MDS with more than or equal to 15% RS (MDS-RS).
33 individualized in patients with a MELD score more than or equal to 15.
34 nalysis included heart transplant recipients more than or equal to 18 years transplanted between Janu
35         The proportion of biopsies with IFTA more than or equal to 2 and the Total Score more than 2
36 ial prostate-specific antigen (PSA) level of more than or equal to 2 ng/mL above the postcryotherapy
37 ic criteria included flow velocity elevation more than or equal to 2 sd above age and gender normal v
38                    Increases in TNFR1 levels more than or equal to 2.5 baseline correlated with event
39 wn-regulated and 550 up-regulated genes with more than or equal to 2.5-fold difference in expression
40 y 37) compared with 82% of alloantigens with more than or equal to 20 mismatched AAs (median fluoresc
41 I) more than or equal to 100 for class I and more than or equal to 200 for class II were the lowest D
42 qual to 60 years (OR: 2.36), body mass index more than or equal to 22 kg/m(2) (OR: 0.60), presence of
43 lly ventilated patients expected to stay for more than or equal to 24 hours; and 3) 2010-2011, mechan
44 d ratio of 0.43 (P=0.006) favoring pump time more than or equal to 24 hr among those with more than o
45 s equally low for pump time less than 24 vs. more than or equal to 24 hr, 5.2% (6/116) vs. 4.0% (9/22
46 , -1.15 to -0.13; p = 0.01) being reduced by more than or equal to 3 days in three studies, 0.1 to le
47                          Evl trough level of more than or equal to 3 ng/mL was associated with signif
48 , or t(14;16)] or plasma cell labeling index more than or equal to 3%.
49  reactive amyloidosis), with Congo red score more than or equal to 3+, and nonaffected controls.
50 0% had International Prognostic Index scores more than or equal to 3.
51 tery to extracranial internal carotid artery more than or equal to 3.
52 e 19 to 21 years (aHR=2.60), body mass index more than or equal to 30 kg/m (aHR=2.17), and use of tac
53  Chronic Health Evaluation II score quartile more than or equal to 30, low-dose corticosteroid was as
54 significantly improved in chimeras receiving more than or equal to 300 cGy TBI plus anti-alphabeta-TC
55 posure groups: hyperoxia was defined as PaO2 more than or equal to 300 mm Hg (39.99 kPa), hypoxia as
56 io, 3.6; 95% CI, 1.1-11.9), respiratory rate more than or equal to 32 cycles/min (odds ratio, 5.6; 95
57           Subjects whose body mass index was more than or equal to 35 kg/m2 (n=8) were found to have
58 dies were significantly decreased by R348 is more than or equal to 40 mg/kg (P</=0.05) and rapamycin
59 n was most effectively suppressed by R348 is more than or equal to 40 mg/kg (P<0.05) and rapamycin 3
60                                      R348 is more than or equal to 40 mg/kg but neither dose of rapam
61                 Animals treated with R348 is more than or equal to 40 mg/kg showed elevated alanine t
62 led patients) and current hospitalization of more than or equal to 5 days (45.3%).
63  received exclusive parenteral nutrition for more than or equal to 5 days, and did not change IV fat
64 act, specific cytogenetic abnormalities with more than or equal to 5 informative cases were identifie
65 onclusion Microwave lung ablations performed more than or equal to 5 mm from the heart were associate
66 erapy and found that 14% had BM plasma cells more than or equal to 5%.
67 m-free light chain ratio had BM plasma cells more than or equal to 5%.
68 y days; the majority (74%) of whom did so on more than or equal to 50% of their creatinine clearance
69 e only evident in patients with class II MFI more than or equal to 500 (estimated glomerular filtrati
70 nto two groups by age: older donors (O) were more than or equal to 55 years old, and younger donors (
71                Recipients with CTA surviving more than or equal to 6 months were evaluated for Treg.
72 o 7.48 (95% CI, 4.49-12.46) for persons with more than or equal to 6 risk alleles.
73 was the percentage of patients who collected more than or equal to 6 x 10(6) CD34(+) cells/kg in less
74 an daily apheresis for up to 4 days or until more than or equal to 6 x 10(6) CD34(+) cells/kg were co
75 atients who survived with insurance benefits more than or equal to 60 days after AMI diagnosis.
76    Compared with patients with 12-month eGFR more than or equal to 60 mL/min/1.73 m, the adjusted rel
77 hronic kidney disease stage 3 had intact PTH more than or equal to 70 pg/mL.
78 uals with plasma inducible protein-10 levels more than or equal to 730 pg/mL had significantly prolon
79 s/min, 50-63 beats/min, 64-77 beats/min, and more than or equal to 78 beats/min, with respective prop
80 an the estimated maternal antibody titre and more than or equal to 8 after three vaccinations.
81 -patients with panel reactive antibody (PRA) more than or equal to 80%.
82 mL and Gleason score of the recurrent cancer more than or equal to 9 are unlikely to be successfully
83 for poliovirus types 1, 2, and 3 with titres more than or equal to four-fold higher than the estimate
84 eters remained unchanged in patients with AR more than or equal to grade II.
85 flow tract procedures in early childhood had more than or equal to moderate pulmonary regurgitation,
86 y, 53.8% PPV, and 93.3% NPV for detection of more than or equal to stage 1 fibrosis.
87 nificantly different between no fibrosis and more than or equal to stage 1 groups, whereas aspartate
88 umors in which the Bcl-2 immunointensity was more than or equal to that of normal colonic mucosa was
89                              For time to INR more than or equal to the lower limit of therapeutic ran
90  surgical intensive care unit length of stay more than or equal to the time from admission to first d
91  a relapse-free survival (RFS) time that was more than or equal to the time from CR1 to RIC-HSCT in t
92 more than or equal to 24 hr among those with more than or equal to two risk factors.
93           Patients with suspected infection, more than or equal to two systemic inflammatory response
94       Cluster analysis showed 628 genes were more than or equal to twofold up- or down-regulated, man

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。